Search | Médecins Sans Frontières Access Campaign

12 results found
There is 1 active filter
Clear all filters
WHO pre-qualification

12 results found

Pharmacy at Batangafo hospital, Central African Republic 2013.

Press release |

26 October 2018

Rapid shift from global to national purchase of TB drugs increases risk of stockouts and use of drugs of unknown quality

Tags Tuberculosis drug-resistant TB stock outWHO pre-qualification Union Conference on Lung HealthThe Global Drug Facility Netherlands

Letter |

17 September 2018

Open Letter to J&J: Calling for affordable access to critical TB drug bedaquiline

MSF sent an open letter to Johnson & Johnson urging the pharmaceutical corporation to take action so that countries can access an affordable and sustainable supply of the critical drug bedaquiline, used to treat multidrug-resistant ...

Tags Tuberculosis drug-resistant TBtuberculosis bedaquiline WHO pre-qualification The Global Drug FacilityUNITAIDUSAIDWorld Health OrganizationJohnson & Johnson

Spotlight |

07 August 2018

Spotlight on: Snakebite

This is the real-life nightmare for 100,000+ people killed by snakebite every year and 400,000 more that are left with life-changing disabilities.

Tags Tropical & neglected diseases snakebite antivenom access to medicinesresearch and development (R&D)substandard & counterfeit medicinestropical medicineWHO pre-qualification Health Action InternationalWorld Health Organization

An MSF nurse performs a Cryptococcal Antigen (CrAg) screening test to test for Cryptococcal Meningitis in an AIDS patient.

Letter |

24 July 2018

MSF calls on Mylan to urgently make its life-saving cryptococcal meningitis treatment more accessible and affordable

Tags HIV/AIDS cryptococcal meningitis antiretroviral medicines opportunistic infectionsWHO pre-qualification World Health Organization

Statement |

23 January 2014

MSF intervention on regulatory systems strengthening at WHO 134th Executive Board meeting

Tags Intellectual property and trade WHO pre-qualification World Health Organization

Video |

12 December 2011

Importance of Prequalification of Artesunate Injection

Tags MalariaTropical & neglected diseases severe malaria quinineartesunate WHO pre-qualification

Technical brief |

22 May 2009

Putting Patients’ Safety First - MSF briefing paper on the quality of medicines

Tags WHO pre-qualification World Health Organization

Research article |

03 October 2008

Substandard medicines in resource-poor settings: a problem that can no longer be ignored

Tags Intellectual property and trade substandard & counterfeit medicinesWHO pre-qualification

Issue brief |

17 January 2005

MSF briefing note regarding WHO pre-qualification for the 115th Session of the WHO Executive Board

Tags Intellectual property and trade WHO pre-qualification World Health AssemblyWorld Health Organization

Issue brief |

16 June 2004

Two Cipla AIDS Drugs Removed from WHO Prequalification List

Tags HIV/AIDS antiretroviral medicineslamivudine WHO pre-qualification World Health OrganizationCipla

Statement |

20 March 2002

Comments by Médecins Sans Frontières to the WHO report

Tags HIV/AIDS HIV/AIDS antiretroviral medicines intellectual property & tradeWHO pre-qualification World Health Organization

Statement |

14 January 2002

MSF Statement for the WHO Executive Board

Tags Intellectual property and trade Doha Declarationresearch and development (R&D)WHO pre-qualification World Health Organization

Date

Primary topics

Types of content

Products

Diseases

General Terms

Geography

Campaigns

Institutions & Events

Report series

Miscellaneous

Rapid shift from global to national purchase of TB drugs increases risk of stockouts and use of drugs of unknown quality

Open Letter to J&J: Calling for affordable access to critical TB drug bedaquiline

Spotlight on: Snakebite

MSF calls on Mylan to urgently make its life-saving cryptococcal meningitis treatment more accessible and affordable

MSF intervention on regulatory systems strengthening at WHO 134th Executive Board meeting

Importance of Prequalification of Artesunate Injection

Putting Patients’ Safety First - MSF briefing paper on the quality of medicines

Substandard medicines in resource-poor settings: a problem that can no longer be ignored

MSF briefing note regarding WHO pre-qualification for the 115th Session of the WHO Executive Board

Two Cipla AIDS Drugs Removed from WHO Prequalification List

Comments by Médecins Sans Frontières to the WHO report

MSF Statement for the WHO Executive Board